CLASS II ONGOING Drug recall · Reported 4 Nov 2026 · FDA Enforcement Report
Oxytocin, 30 USP Units, Added to 0.9% Sodium Chloride recalled
Eagle Pharma Outsourcing is recalling Oxytocin, 30 USP Units, Added to 0.9% Sodium Chloride - Single-Use Container, distributed nationwide in the US. The recall was initiated on 8 Oct 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0106-2027
- FDA event ID
- 100073
- Recalling firm
- Eagle Pharma Outsourcing, Hoover, AL
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 8 Oct 2026
- FDA classified
- 28 Oct 2026
- Reported
- 4 Nov 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 8 Oct 2026 | Recall initiated by company | |
| 28 Oct 2026 | Classified by FDA | +20 days |
| 4 Nov 2026 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50
Where it was distributed
Nationwide within the U.S
Questions about this recall
Why was it recalled?
Lack of Assurance of Sterility
Which lots are affected?
Lot: OXY30-1006, Expiry: 10/10/2026.
Where was it sold?
Nationwide within the U.S
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 10 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 100073This product is part of a recall event; the main page for the event is PHENYLephrine HCL Infusion, 100 mg recalled by Eagle Pharma Outsourcing.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | PHENYLephrine HCL Infusion, 100 mg recalled by Eagle Pharma Outsourcing | Eagle Pharma Outsourcing | Sterility | Nationwide |
More recalls from Eagle Pharma Outsourcing
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | PHENYLephrine HCL Infusion, 100 mg recalled by Eagle Pharma Outsourcing | Eagle Pharma Outsourcing | Sterility | Nationwide |
Other Oxytocin recalls
All 15| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Oxytocin for Injection, all strengths and presentations recalled | GenoGenix | Sterility | Nationwide |
| Drug | CLASS III | oxyTOCIN/mL) added to 0.9% Sodium Chloride, Injection recalled | QuVa Pharma | Packaging Defects | Nationwide |
| Drug | CLASS II | Oxytocin/mL) in 0.9% Sodium Chloride Injection, USP IV recalled | Nephron Sterile Compounding Center | Sterility | Nationwide |
| Drug | CLASS II | Oxytocin/mL) in 0.9% Sodium Chloride Injection recalled | Nephron Sterile Compounding Center | Sterility | Nationwide |
| Drug | CLASS II | oxyTOCIN/mL) added to 0.9% Sodium Chloride Injection for IV Use recalled | QuVa Pharma | Potency & Assay | Nationwide |